Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Mooney

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Epidemiology (Cambridge, Mass.)|January 2, 2026
Limitations (with apologies to Sir Philip Sidney)Stephen J Mooney
American Journal of Epidemiology|March 25, 2017
Invited Commentary: The Tao of Clinical Cohort Analysis-When the Transitions That Can Be Spoken of Are Not the True TransitionsStephen J Mooney
Epidemiology (Cambridge, Mass.)|May 19, 2026
Why Should We Scan for Heterogeneous Treatment Effects?Stephen J Mooney
American Journal of Epidemiology|January 12, 2022
TWO STUDY DESIGNS WALK INTO A BAR…Daniel Westreich, Stephen J Mooney
Annual Review of Public Health|December 21, 2017
Big Data in Public Health: Terminology, Machine Learning, and PrivacyStephen J Mooney, Vikas Pejaver
Epidemiology (Cambridge, Mass.)|October 1, 2019
Number (of Whom?) Needed to Treat (with What?): Exposures, Population Interventions, and the Number Needed to TreatDaniel Westreich, Stephen J Mooney
Current Epidemiology Reports|July 31, 2019
Sampling and Sampling Frames in Big Data EpidemiologyStephen J Mooney, Michael D Garber
International Journal of Epidemiology|August 16, 2016
The epidemiologic principles underlying traffic safety study designsJune H Kim, Stephen J Mooney
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 5, 2025
Can We Interpret Analyses of Etiologic Heterogeneity When Molecular Markers Are Used to Classify Tumors?Stephen J Mooney, Andrew G Rundle
Social Science & Medicine (1982)|December 7, 2015
Stigma and the etiology of depression among the obese: An agent-based explorationStephen J Mooney, Abdulrahman M El-Sayed
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Epidemiology (Cambridge, Mass.)|January 2, 2026
Limitations (with apologies to Sir Philip Sidney)Stephen J Mooney
American Journal of Epidemiology|March 25, 2017
Invited Commentary: The Tao of Clinical Cohort Analysis-When the Transitions That Can Be Spoken of Are Not the True TransitionsStephen J Mooney
Epidemiology (Cambridge, Mass.)|May 19, 2026
Why Should We Scan for Heterogeneous Treatment Effects?Stephen J Mooney
American Journal of Epidemiology|January 12, 2022
TWO STUDY DESIGNS WALK INTO A BAR…Daniel Westreich, Stephen J Mooney
Annual Review of Public Health|December 21, 2017
Big Data in Public Health: Terminology, Machine Learning, and PrivacyStephen J Mooney, Vikas Pejaver
Epidemiology (Cambridge, Mass.)|October 1, 2019
Number (of Whom?) Needed to Treat (with What?): Exposures, Population Interventions, and the Number Needed to TreatDaniel Westreich, Stephen J Mooney
Current Epidemiology Reports|July 31, 2019
Sampling and Sampling Frames in Big Data EpidemiologyStephen J Mooney, Michael D Garber
International Journal of Epidemiology|August 16, 2016
The epidemiologic principles underlying traffic safety study designsJune H Kim, Stephen J Mooney
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 5, 2025
Can We Interpret Analyses of Etiologic Heterogeneity When Molecular Markers Are Used to Classify Tumors?Stephen J Mooney, Andrew G Rundle
Social Science & Medicine (1982)|December 7, 2015
Stigma and the etiology of depression among the obese: An agent-based explorationStephen J Mooney, Abdulrahman M El-Sayed
Pageof 16